Market by Product Type, Disease Indication, Distribution Channel, Delivery Mode, and Country Outlook | Forecast 2023-2030
Triton Market Research’s report implies that North America’s insulin patch pump market will advance with a CAGR of 11.00% in the forecast period from 2023 to 2030.
Report scope can be customized per your requirements - Request Free Sample Report
The countries analyzed in this region include:
• Canada
• The United States
Canada
is estimated to exhibit the fastest growth in the regional market over the
forecasted period. The rising prevalence of
diabetes is expected to fuel the insulin patch pump market’s growth in the
region. Medical devices in the US and Canada are classified on the basis of
risk and require prior approval before entering the market. This approval process
can, at times, become cumbersome. Thus, stringent government regulations are
expected to restrict the market’s growth in the region over the forecast period.
Canada has contributed tremendously
towards the advancements in diabetes prevention and treatment techniques.
According to the country’s government, the prevalence rate of diabetes has been
increasing at an average of 3.3% every year. The growing disease prevalence,
together with the rising investments in healthcare R&D, is expected to
drive the insulin patch pump market’s growth during the forecast period.
Diabetes is one of the
leading causes of mortality in the United States. In 2019, close to 37.3
million Americans or 11.3% of the population, reported to have been affected by
the condition, according to data from the American Diabetes Association (ADA).
About 1.4 million new
cases are reported every year. In addition, approximately 26.4 million people
aged 65 years or above have pre-diabetes, according to the CDC. The
above-stated factors are expected to drive the demand for insulin patch pumps
in the country. This, in turn, will drive the market growth, supported by a
high per capita income and the rising healthcare expenditure.
An online pharmacy operates
over the internet and dispatches orders to buyers via shipping companies’
services. The growth of the online distribution channel and the convenience
offered by online shopping are expected to contribute to the segment’s growth.
The
studied report assesses the market according to distribution channel, delivery
mode, product type, and disease indication. Here,
the distribution channel segment comprises online pharmacies, retail
pharmacies, and hospital pharmacies.
The
noteworthy players in the insulin patch pump market include F Hoffmann La Roche
AG, CeQur SA, Medtronic Plc, Medtrum Technologies Inc, and Debiotech SA.
Tandem Diabetes Care
Inc is a US-based insulin delivery and diabetes technology company. It offers a
range of products for diabetes patients. The company’s product portfolio includes
pumps with different technologies, infusion sets, as well as pump-related
supplies and accessories. Some of the key products include T:Slim x2 insulin
pump with basal-IQ technology, T:Slim x2 insulin pump as a stand-alone pump,
and T:Slim x2 insulin pump with control-IQ technology. Founded in 2006, Tandem
Diabetes Care is headquartered in San Diego, California.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2023-2030
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the insulin patch pump market revenue growth in
North America and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces
·
A
wide-ranging study of factors that will challenge the North America insulin
patch pump market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
1. NORTH
AMERICA INSULIN PATCH PUMP MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PARENT
MARKET ANALYSIS
2.2. IMPACT
ANALYSIS ON THE INSULIN PATCH PUMP MARKET
2.2.1. COVID-19
IMPACT
2.2.2. UKRAINE-RUSSIA
WAR IMPACT
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
MATURITY ANALYSIS
2.5. INDUSTRY
COMPONENTS
2.5.1. RESEARCH
AND DEVELOPMENT
2.5.2. DEVELOPMENT
OF PRODUCT
2.5.3. DISTRIBUTION
2.6. REGULATORY
FRAMEWORK
2.7. KEY
BUYING IMPACT ANALYSIS
2.7.1. PRICE
2.7.2. PROPERTIES
OF PRODUCT
2.7.3. PURPOSE
2.8. KEY
MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT
LAUNCHES
2.8.3. MERGERS
& ACQUISITIONS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AWARENESS ABOUT INSULIN PATCH PUMPS
2.9.2. INTEGRATION
OF ADVANCED TECHNOLOGIES
2.9.3. RISING
PREVALENCE OF DIABETES AROUND THE GLOBE
2.10. MARKET
CHALLENGES
2.10.1. RISKS
RELATED TO THE USE OF INSULIN PUMPS
2.10.2. LACK
OF KNOWLEDGE PERTAINING TO USAGE
2.10.3. STRICT
REGULATIONS BY GOVERNMENT AUTHORITIES
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
POPULARITY OF GLUCOSE MONITORING SYSTEMS
2.11.2. USE
OF ARTIFICIAL INTELLIGENCE & MACHINE LEARNING FOR MANUFACTURING OF INSULIN
PUMPS
2.11.3. GROWING
EXPENDITURE ON DIABETES CARE
2.11.4. RISING
DEMAND FOR MINIMALLY INVASIVE DELIVERY SYSTEMS
2.12. ANALYST
PERSPECTIVE
3. NORTH
AMERICA INSULIN PATCH PUMP MARKET – BY PRODUCT TYPE
3.1. DISPOSABLE
3.2. REUSABLE
4. NORTH
AMERICA INSULIN PATCH PUMP MARKET – BY DISEASE INDICATION
4.1. TYPE
1 DIABETES
4.2. TYPE
2 DIABETES
5. NORTH
AMERICA INSULIN PATCH PUMP MARKET – BY DELIVERY MODE
5.1. BASAL
5.2. BOLUS
5.3. BASAL
& BOLUS
6. NORTH
AMERICA INSULIN PATCH PUMP MARKET – BY DISTRIBUTION CHANNEL
6.1. ONLINE
PHARMACIES
6.2. RETAIL
PHARMACIES
6.3. HOSPITAL
PHARMACIES
7. NORTH
AMERICA INSULIN PATCH PUMP MARKET – COUNTRY OUTLOOK
7.1. COUNTRY
ANALYSIS
7.1.1. UNITED
STATES
7.1.1.1. UNITED
STATES INSULIN PATCH PUMP MARKET FORECAST & PROSPECTS
7.1.2. CANADA
7.1.2.1. CANADA
INSULIN PATCH PUMP MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. MEDTRONIC
PLC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. F
HOFFMANN LA ROCHE AG
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. INSULET
CORPORATION
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. TANDEM
DIABETES CARE INC
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEQUR
SA
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. MEDTRUM
TECHNOLOGIES INC
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. DEBIOTECH
SA
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. TERUMO
CORPORATION
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. EOFLOW
CO LTD
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 7: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY DISEASE INDICATION, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY DELIVERY MODE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: INSULIN
DELIVERY SYSTEMS
FIGURE 2: MARKET MATURITY
ANALYSIS
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: KEY BUYING
IMPACT ANALYSIS
FIGURE 5: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 6: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY DISPOSABLE, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY REUSABLE, 2023-2030 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY DISEASE INDICATION, 2022 & 2030 (IN %)
FIGURE 9: NORTH AMERICA
INSULIN PATCH PUMP MARKET, BY TYPE 1 DIABETES, 2023-2030 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY TYPE 2 DIABETES, 2023-2030 (IN $ MILLION)
FIGURE 11: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY DELIVERY MODE, 2022 & 2030 (IN %)
FIGURE 12: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY BASAL, 2023-2030 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY BOLUS, 2023-2030 (IN $ MILLION)
FIGURE 14: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY BASAL & BOLUS, 2023-2030 (IN $
MILLION)
FIGURE 15: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN
%)
FIGURE 16: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY ONLINE PHARMACIES, 2023-2030 (IN $
MILLION)
FIGURE 17: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $
MILLION)
FIGURE 18: NORTH
AMERICA INSULIN PATCH PUMP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $
MILLION)
FIGURE 19: NORTH
AMERICA INSULIN PATCH PUMP MARKET, COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 20: UNITED
STATES INSULIN PATCH PUMP MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: CANADA
INSULIN PATCH PUMP MARKET 2023-2030 (IN $ MILLION)